R C Liu1, L W Traverso. 1. Section of General, Vascular, and Thoracic Surgery, Virginia Mason Medical Center, 1100 Ninth Avenue, C6-GSurg, 900, Seattle, WA 98111, USA.
Abstract
BACKGROUND: Computed tomography (CT) is insensitive to small metastatic deposits in patients with pancreatic cancer. This study aimed to evaluate additional staging information obtained by laparoscopy in the subset of patients with locally extending pancreatic cancer but no evidence of distant disease using computed tomography. METHODS: Between April 2000 and February 2004, 74 patients with locally unresectable pancreatic cancer and no evidence of metastasis detected by high-quality pancreas protocol computed tomography underwent outpatient staging laparoscopy and peritoneal lavage cytology. RESULTS: Occult tumor was found during staging laparoscopy in 25 of the 74 patients (34%). The results were positive for peritoneal lavage cytology in 27% (20/74), for liver lesions in 16% (12/74), and for peritoneal implants in 7% (5/74) of the patients. Body and tail tumors were twice as likely as pancreatic head tumors to have unsuspected metastasis (53% vs 28%). CONCLUSIONS: Even the best computed tomography scan is not adequate for accurate staging of locally extended pancreatic cancer because occult distant disease will be found in half of the patients with left-sided disease and one-fourth of those with right-sided pancreatic cancer.
BACKGROUND: Computed tomography (CT) is insensitive to small metastatic deposits in patients with pancreatic cancer. This study aimed to evaluate additional staging information obtained by laparoscopy in the subset of patients with locally extending pancreatic cancer but no evidence of distant disease using computed tomography. METHODS: Between April 2000 and February 2004, 74 patients with locally unresectable pancreatic cancer and no evidence of metastasis detected by high-quality pancreas protocol computed tomography underwent outpatient staging laparoscopy and peritoneal lavage cytology. RESULTS:Occult tumor was found during staging laparoscopy in 25 of the 74 patients (34%). The results were positive for peritoneal lavage cytology in 27% (20/74), for liver lesions in 16% (12/74), and for peritoneal implants in 7% (5/74) of the patients. Body and tail tumors were twice as likely as pancreatic head tumors to have unsuspected metastasis (53% vs 28%). CONCLUSIONS: Even the best computed tomography scan is not adequate for accurate staging of locally extended pancreatic cancer because occult distant disease will be found in half of the patients with left-sided disease and one-fourth of those with right-sided pancreatic cancer.
Authors: R R White; H I Hurwitz; M A Morse; C Lee; M S Anscher; E K Paulson; M R Gottfried; J Baillie; M S Branch; P S Jowell; K M McGrath; B M Clary; T N Pappas; D S Tyler Journal: Ann Surg Oncol Date: 2001-12 Impact factor: 5.344
Authors: S D Leach; J A Rose; A M Lowy; J E Lee; C Charnsangavej; J L Abbruzzese; R L Katz; D B Evans Journal: Surgery Date: 1995-09 Impact factor: 3.982
Authors: E Luque-de Leôn; G G Tsiotos; B Balsiger; J Barnwell; L J Burgart; M G Sarr Journal: J Gastrointest Surg Date: 1999 Mar-Apr Impact factor: 3.267
Authors: Mustafa Suker; Berend R Beumer; Eran Sadot; Lysiane Marthey; Jason E Faris; Eric A Mellon; Bassel F El-Rayes; Andrea Wang-Gillam; Jill Lacy; Peter J Hosein; Sing Yu Moorcraft; Thierry Conroy; Florian Hohla; Peter Allen; Julien Taieb; Theodore S Hong; Ravi Shridhar; Ian Chau; Casper H van Eijck; Bas Groot Koerkamp Journal: Lancet Oncol Date: 2016-05-06 Impact factor: 41.316
Authors: Thejus T Jayakrishnan; Hasan Nadeem; Ryan T Groeschl; Ben George; James P Thomas; Paul S Ritch; Kathleen K Christians; Susan Tsai; Douglas B Evans; Sam G Pappas; T Clark Gamblin; Kiran K Turaga Journal: HPB (Oxford) Date: 2014-08-15 Impact factor: 3.647
Authors: Nestor F Esnaola; Uzair B Chaudhary; Paul O'Brien; Elizabeth Garrett-Mayer; E Ramsay Camp; Melanie B Thomas; David J Cole; Alberto J Montero; Brenda J Hoffman; Joseph Romagnuolo; Kelly P Orwat; David T Marshall Journal: Int J Radiat Oncol Biol Phys Date: 2014-03-15 Impact factor: 7.038
Authors: Elliot Tapper; Bobby Kalb; Diego R Martin; David Kooby; N Volkan Adsay; Juan M Sarmiento Journal: HPB (Oxford) Date: 2011-08-19 Impact factor: 3.647
Authors: M Hidalgo; A Abad; E Aranda; L Díez; J Feliu; C Gómez; A Irigoyen; R López; F Rivera; C Rubio; J Sastre; J Tabernero; E Díaz-Rubio Journal: Clin Transl Oncol Date: 2009-05 Impact factor: 3.405
Authors: C K Enestvedt; S C Mayo; B S Diggs; M Mori; D A Austin; D K Shipley; B C Sheppard; K G Billingsley Journal: J Gastrointest Surg Date: 2008-05-10 Impact factor: 3.452